The last few days have seen a flurry of biotech IPO news, with Alamar, Hemab, Kailera, and Seaport all pushing for Nasdaq listings.

The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing to adequately communicate the indication, contraindications

Click Therapeutics cut more than a quarter of its workforce shortly after raising Series D funding, Endpoints News has learned. The digital therapeutics startup, which

Biotechs with single products in the market are likely on edge about how President Donald Trump’s pharma tariffs and “most favored nation” pricing will play

The FDA is getting closer to announcing a director of the Center for Biologics Evaluation and Research, sources told Endpoints News, following the controversial tenure